How matrix metalloproteinases regulate cell behavior

Annual Review of Cell and Developmental Biology

Volumn 17, Issue , 2001, Pages 463-516

  Sternlicht, M D ^a   Werb, Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular matrix; Proteinases; Proteolytic signaling; Tissue inhibitors of metalloproteinases

Indexed keywords

BINDING PROTEIN; BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CHEMOTACTIC FACTOR; COLLAGENASE 3; COLLAGENASE 4; ENAMELYSIN; ENDOMETASE; EPILYSIN; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 27; METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; PROTEIN CMMP; PROTEIN MT1 MMP; PROTEIN MT2 MMP; PROTEIN MT3 MMP; PROTEIN MT4 MMP; PROTEIN MT5 MMP; PROTEIN MT6 MMP; PROTEIN RASI 1; PROTEIN XMMP; PROTEINASE; PROTEINASE INHIBITOR; SCLEROPROTEIN; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; CARCINOGENESIS; CELL FUNCTION; CONFERENCE PAPER; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; GENE CONTROL; GENE MUTATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BONE AND BONES; CELL COMMUNICATION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSCRIPTION, GENETIC;

EID: 0035188727     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.17.1.463     Document Type: Conference Paper

References (230)

1. Cloning and characterization of ADAMTS 11, an aggrecanase from the ADAMTS family
2. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinase-1 transgene
3. Stromelysin-1 regulates adipogenesis during mammary gland involution
4. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome
5. Fibrillin degradation by matrix metalloproteinases: Implications for connective tissue remodelling
6. Identifcation and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
7. α1-Proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase
8. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells
9. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization
10. Collagenase production by human skin fibroblasts
11. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity
12. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion
13. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
14. Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury
15. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B
16. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter
17. Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases)
18. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity
19. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells
20. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
21. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin ανβ3
22. Functions of lipid rafts in biological membranes
23. The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice
24. Impaired wound contraction in stromelysin-1-deficient mice
25. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A
26. The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells
27. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinase-1
28. cDNA cloning and expression of bovine procollagen I N-proteinase: A new member of the super-family of zinc-metalloproteinases with binding sites for cells and other matrix components
29. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
30. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
31. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
32. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema
33. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis
34. Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms
35. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library
36. MT1-MMP initiates activation of pro-MMP-2 and integrin ανβ3 promotes maturation of MMP-2 in breast carcinoma cells
37. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by α1-antitrypsin
38. Collagenase induction promotes mouse tumorigenesis by two independent pathways
39. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
40. Matrilysin expression and function in airway epithelium
41. Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective
42. The tissue inhibitors of metalloproteinases (TIMPs)
43. The role of αν integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
44. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-α convertase activity but does not activate pro-MMP2
45. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
46. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
47. Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
48. Matrilysin (MMP-7) expression selects for apoptosis-resistant tumor cells
49. Regulation of matrix metalloproteinase gene expression
50. MMPs are IGFBP-degrading proteinases: Implications for cell proliferation and tissue growth
51. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
52. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5
53. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
54. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
55. Collagenolytic activity in amphibian tissues: A tissue culture assay
56. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinase-1
57. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface
58. Isolation and characterization of two novel metalloproteinase genes linked to the CdC2L locus on human chromosome 1p36.3
59. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites
60. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice
61. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
62. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption
63. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption
64. The zymogen of tadpole collagenase
65. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases
66. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice
67. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis
68. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
69. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII
70. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
71. Tissue inhibitor of metalloproteinase-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition
72. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
73. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
74. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site
75. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases
76. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release
77. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2
78. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture
79. Antiangiogenic domains shared by thrombospondins and metallospondins, a new family of angiogenic inhibitors
80. Degradation of interleukin 1β by matrix metalloproteinases
81. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
82. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface
83. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase
84. Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Caurati-Engelmann disease
85. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation
86. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease
87. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region
88. TIMP-3 is a potent inhibitor of ADAM-TS4 (aggrecanase 1) and ADAMTS5 (aggrecanase 2)
89. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of α-proteinase inhibitor generated by matrix metalloproteinases: A possible modulatory role in natural killer cytotoxicity
90. Role of Racl and oxygen radicals in collagenase-1 expression induced by cell shape change
91. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of metalloproteinases-1
92. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
93. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semi-quantitative PCR-based assay
94. Primary structure and expression of a gamete lytic enzyme in Chlamydomonas reinhardtii: Similarity of functional domains to matrix metalloproteases
95. Landscaping the cancer terrain
96. Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis
97. Membrane-type 6 matrix metalloproteinase (MT6-MMP,MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP
98. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth
99. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro
100. Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice
101. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression
102. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation
103. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy
104. MMP9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity
105. A novel hydra matrix metalloproteinase (HMMP) functions in extracellular matrix degradation, morphogenesis and the maintenance of differentiated cells in the foot process
106. Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo
107. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1
108. Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta
109. Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation
110. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling
111. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo
112. Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development
113. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
114. T-antigen inhibits metalloproteinase expression and invasion in human placental cells transformed with temperature-sensitive simian virus 40
115. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene
116. Epilysin: A novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury
117. Multiple regulatory elements in the murine stromelysin-3 promoter. Evidence for direct control by CCAAT/enhancer-binding protein b and thyroid and retinoid receptors
118. ECM signalling: Orchestrating cell behaviour and misbehaviour
119. Functional overlap between two classes of matrix-degrading proteases in wound healing
120. Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties
121. Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity
122. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3
123. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells
124. Matrix metalloproteinase 2 gene (MMP-2) mutations cause a multicentric osteolysis and arthritis syndrome
125. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1
126. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice
127. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
128. Cancer biology: Extracellular proteinases in malignancy
129. Sequencing and characterization of the soybean leaf metalloproteinase: Structural and functional similarity to the matrix metalloproteinase family
130. A functional proteomics screen of proteases in colorectal carcinoma
131. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
132. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity
133. Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A
134. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling
135. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis
136. Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor
137. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction
138. Murine matrix metalloproteinase 9 gene. 5′-upstream region contains cis-acting elements for expression in osteoclasts and migrating keratinocytes in transgenic mice
139. The role of the C-terminal domain in collagenase and stromelysin specificity
140. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant
141. Tissue inhibitors of matrix metalloendopeptidases
142. Matrix metalloproteinases
143. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
144. Matrix metalloproteinases: Biologic activity and clinical implications
145. Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis
146. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
147. Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities
148. Loss of heterozygosity on chromosome q22-q23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter
149. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance
150. Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: Importance of the N-terminal region between cysteine 3 and cysteine 13
151. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator
152. High affinity binding of latent matrix metalloproteinase-9 to the α2(IV) chain of collagen IV
153. Hyper-resistance to infection in TIMP-1-deficient mice is neutrophil dependent but not immune cell autonomous
154. Matrix metalloproteinase substrate binding domains, modules and exosites
155. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression
156. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor
157. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
158. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
159. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13)
160. An essential role for ectodomain shedding in mammalian development
161. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo
162. Integrin ανβ3 promotes M21 melanoma growth in human skin by regulating tumor cell survival
163. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2
164. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity
165. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
166. Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization
167. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes
168. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: Role of Sp1 in allele-specific transcriptional regulation
169. The ADAM gene family: Surface proteins with adhesion and protease activity
170. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
171. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells
172. Proteinase-activated receptor-1 regulation of macrophage elastase (MMP-12) secretion by serine proteinases
173. Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility
174. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis
175. Digestion of C1q collagen-like domain with MMPs-1,-2,-3, and -9 further defines the sequence involved in the stimulation of neutrophil superoxide production
176. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription
177. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins
178. A novel role of metalloproteinase in cancer-mediated immunosuppression
179. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats
180. Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases-1 (TIMP-1)
181. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors
182. Disruption of matrix metalloproteinase 2 binding to integrin ανβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
183. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host
184. Human fibroblast collagenase-α-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian α-macroglobulins
185. Matrix metalloproteinases as emerging targets in anti-cancer therapy: Status and prospects
186. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
187. Biology and regulation of the matrix metalloproteinases
188. The stromal proteinase MMP-3/stromelysin-1 promotes mammary carcinogenesis
189. ECM proteinases
190. The metzincins - Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases
191. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19
192. Extracellular matrix remodelling and cellular differentiation
193. Structural analysis of the integrin α2:matrix metalloproteinase-1 interaction
194. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
195. p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression
196. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
197. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
198. ADAMTS: A novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats
199. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
200. Biosynthesis of α2(IV) and α1(IV) chains of collagen IV and interactions with matrix metalloproteinase-9
201. Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts
202. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
203. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
204. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes
205. The discoidin domain receptor tyrosine kinases are activated by collagen
206. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
207. Cloning of three Caenorhabditis elegans genes potentially encoding novel matrix metalloproteinases
208. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response
209. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury
210. TIMP-2 is required for efficient activation of proMMP-2 in vivo
211. ECM and cell surface proteolysis: Regulating cellular ecology
212. A cellular striptease act
213. Structure-function relationships in the tissue inhibitors of metalloproteinases
214. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia
215. Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation
216. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
217. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense
218. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters
219. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions
220. Defective trophoblast function in mice with a targeted mutation of Ets2
221. Matricellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2
222. Extracellular MMP2 levels are regulated by the low-density lipoprotein-related scavenger receptor and thrombospondin 2
223. Polymorphism in matrix metalloproteinase gene promoters: Implication in regulation of gene expression and susceptibility of various diseases
224. Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression
225. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis
226. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
227. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis
228. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I
229. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)